Will AstraZeneca-Oxford's coronavirus vaccine protect you from disease?
November 24 2020, 08:00
While Oxford University and AstraZeneca announced Monday that their coronavirus vaccine candidate reached up to 90% efficacy in a late-stage clinical trial, the vaccine still requires regulatory approval before distribution.
While Oxford University and AstraZeneca announced Monday that their coronavirus vaccine candidate reached up to 90% efficacy in a late-stage clinical trial, the vaccine still requires regulatory approval before distribution.
Source:
FOX News